Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Strategic Use of New Generation Antidepressants for Depression | Clinical Trials | Clareo Health

Back to search

COMPLETEDPhase 4

Strategic Use of New Generation Antidepressants for Depression

NCT01109693•Kyoto University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Unipolar Major Depressive Episode

Interventions

Sertraline

Mirtazapine

Locations

Japan

Locations (2)

Nagoya City University Hospital

Nagoya, Aichi-ken, Japan

Kochi Medical School Hospital

Nangoku, Kochi, Japan

Key Dates

Start Date

December 1, 2010

Primary Completion Date

September 1, 2015

Completion Date

December 1, 2015

Last Updated

October 3, 2016

Sponsors

Lead Sponsor

Kyoto University

Collaborators

National Center of Neurology and Psychiatry, Japan

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 3, 2016Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions